Correlation Between InMed Pharmaceuticals and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InMed Pharmaceuticals and Fortress Biotech Pref, you can compare the effects of market volatilities on InMed Pharmaceuticals and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Fortress Biotech.

Diversification Opportunities for InMed Pharmaceuticals and Fortress Biotech

0.81

Correlation Coefficient

InMed Pharmaceuticals  Fortress Biotech

Very poor diversification

The 3 months correlation between InMed and Fortress is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Fortress Biotech Pref in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech Pref and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech Pref has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Fortress Biotech go up and down completely randomly.

Pair Corralation between InMed Pharmaceuticals and Fortress Biotech

Considering the 90-day investment horizon InMed Pharmaceuticals is expected to under-perform the Fortress Biotech. In addition to that, InMed Pharmaceuticals is 1.99 times more volatile than Fortress Biotech Pref. It trades about -0.06 of its total potential returns per unit of risk. Fortress Biotech Pref is currently generating about -0.03 per unit of volatility. If you would invest  656.00  in Fortress Biotech Pref on September 3, 2024 and sell it today you would lose (65.00) from holding Fortress Biotech Pref or give up 9.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

InMed Pharmaceuticals  vs.  Fortress Biotech Pref

InMed Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days InMed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Fortress Biotech Pref

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fortress Biotech Pref has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest uncertain performance, the Preferred Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with InMed Pharmaceuticals and Fortress Biotech

The main advantage of trading using opposite InMed Pharmaceuticals and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind InMed Pharmaceuticals and Fortress Biotech Pref pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.